Note: Ingredients listed on restricted chemical lists
EC/CAS
7732-18-5
Name of the chemical
Water, distilled, conductivity or of similar purity H2O
Concentration
N/A
General Information
Revision date
2009-10-01
Product name
Dicamba is a benzoic acid derivative, present here as the dimethylamine salt
Product name
Dicamba is a benzoic acid derivative, present here as the dimethylamine salt
Identification on the label/Trade name
FarmaLinx Dicam Herbicide
Substance name
Dicamba is a benzoic acid derivative, present here as the dimethylamine salt
Icons in SDS
Company Information
company name
FARMALINX Pty Ltd
Section 2
Hazard statements
This product is classified as: Xn, Harmful. Xi, Irritating. Hazardous according to the criteria of SWA. Not a Dangerous Good according to the Australian Dangerous Goods (ADG) Code. R22, R36. Harmful if swallowed. Irritating to eyes
Precautionary statements
S20, S23, S36, S61, S24/25. When using, do not eat or drink. Do not breathe spray mists. Wear suitable protective clothing. Avoid release to the environment. Refer to special instructions/Safety Data Sheets. Avoid contact with skin and eyes.
SUSDP Classification
S6
ADG classification
None allocated. Not a Dangerous Good under the ADG Code
UN Number
None allocated Emergency Overview Physical Description & Colour: Clear colourless liquid. Odour: Mild but characteristic odour.
Health hazards
Symptoms of poisoning with Dicamba include loss of appetite (anorexia), vomiting, muscle weakness, slowed heart rate, shortness of breath, central nervous system effects (victim may become excited or depressed), benzoic acid in the urine, incontinence, cyanosis (bluing of the skin and gums), and exhaustion following repeated muscle spasms. In addition to these symptoms, inhalation can cause irritation of the linings of the nasal passages and the lungs, and loss of voice. This product is harmful if swallowed, eye irritant.
Potential health effects
Inhalation: Short Term Exposure: Available data indicates that this product is not harmful. However product may be mildly irritating, although unlikely to cause anything more than mild transient discomfort. Long Term Exposure: No data for health effects associated with long term inhalation. Skin Contact: Short Term Exposure: Available data indicates that this product is not harmful. It should present no hazards in normal use. However product may be irritating, but is unlikely to cause anything more than mild transient discomfort. Long Term Exposure: No data for health effects associated with long term skin exposure. Eye Contact: Short Term Exposure: This product is an eye irritant. Symptoms may include stinging and reddening of eyes and watering which may become copious. Other symptoms may also become evident. If exposure is brief, symptoms should disappear once exposure has ceased. However, lengthy exposure or delayed treatment may cause permanent damage. Long Term Exposure: No data for health effects associated with long term eye exposure. Ingestion: Short Term Exposure: Significant oral exposure is considered to be unlikely. Available data shows that this product is harmful; see symptoms above. However, this product is an oral irritant. Symptoms may include burning sensation and reddening of skin in mouth and throat. Other symptoms may also become evident, but all should disappear once exposure has ceased. Long Term Exposure: No data for health effects associated with long term ingestion. Carcinogen Status: SWA: No significant ingredient is classified as carcinogenic by SWA. NTP: No significant ingredient is classified as carcinogenic by NTP. IARC: No significant ingredient is classified as carcinogenic by IARC.